{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:34:12Z","timestamp":1779935652621,"version":"3.53.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170699"],"award-info":[{"award-number":["82170699"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870469"],"award-info":[{"award-number":["81870469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hospital of Nanjing Medical University","award":["333"],"award-info":[{"award-number":["333"]}]},{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["WSN-010"],"award-info":[{"award-number":["WSN-010"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and hypothesis<\/jats:title>\n                    <jats:p>Evidence from the VALIGA Immunoglobulin A (IgA) nephropathy (IgAN) cohort supports the clinical value of subclassifying focal segmental glomerulosclerosis lesions (S). Our study aimed to validate and explore the clinical significance of S subclassification in an Asian population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 746 patients with IgAN were retrospectively included. The chi-squared automatic interaction detection method was used to identify subgroups of S lesions associated with proteinuria, eGFR, and major adverse kidney events (MAKE). Kaplan\u2013Meier analysis was performed to assess differences in MAKE. Hazard ratios for S1 lesions with respect to MAKE were estimated using Cox proportional hazards regression models. Propensity score analysis was used to evaluate whether immunosuppressive therapy was associated with a favorable outcome within subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 746 patients, S1 lesions were present in 80% of individuals, with segmental capillary occlusion by matrix (not otherwise specified (NOS), 69%), simple capsular adhesion without capillary occlusion (Adh, 63%), and podocyte hypertrophy (PH, 16%) being the top three subtypes. All three lesion types were associated with proteinuria, and NOS was also correlated with eGFR. Patients in the S1 with NOS+Adh+ subgroup had the worst prognosis. Moreover, immunosuppressive therapy was associated with better outcomes in S1 patients with NOS+Adh+. Subgroup analysis showed that the effect of NOS+Adh+ lesions on MAKE was significantly influenced by systolic blood pressure (SBP). Patients with NOS+Adh+ lesions and SBP &amp;gt;130 mmHg had a significantly increased risk of MAKE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study validated the clinical value of S subclassification in IgAN in an Asian population. Patients with NOS+Adh+ lesions have more severe proteinuria and renal function damage. Their overall renal prognosis is significantly worse; however, they can benefit from a treatment strategy that combines renin\u2013angiotensin system inhibitors with immunosuppressants. In addition, controlling SBP to below 130 mmHg seems to be an appropriate range.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfaf162","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T11:53:05Z","timestamp":1755258785000},"page":"297-308","source":"Crossref","is-referenced-by-count":3,"title":["Clinical significance of focal segmental glomerulosclerosis subclassification in IgA nephropathy"],"prefix":"10.1093","volume":"41","author":[{"given":"Fang","family":"Lu","sequence":"first","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Hou","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]},{"name":"Jiangsu Provincial People's Hospital Suqian Hospital Department of Nephrology, , Suqian ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wu","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Pan","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Wu","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Shu","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Mao","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiekun","family":"Li","sequence":"additional","affiliation":[{"name":"Nanjing Kingmed Center for Clinical Laboratory Co., Ltd , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changying","family":"Xing","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyan","family":"Duan","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanggang","family":"Yuan","sequence":"additional","affiliation":[{"name":"the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University Department of Nephrology, , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"2026013001372738300_bib1","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis Prime"},{"key":"2026013001372738300_bib2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026013001372738300_bib3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1001\/jamainternmed.2019.0600","article-title":"Evaluating a new international risk-prediction tool in IgA nephropathy","volume":"179","author":"Barbour","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2026013001372738300_bib4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford Classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib5","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.2014.63","article-title":"Validation of the Oxford Classification of IgA nephropathy in cohorts with different presentations and treatments","volume":"86","author":"Coppo","year":"2014","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford Classification of IgA nephropathy: pathology definitions, correlations, and reproducibility","volume":"76","author":"Working Group of the International IgA Nephropathy Network and the Renal Pathology Society","year":"2009","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford Classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"Working Group of the International IgA Nephropathy Network and the Renal Pathology Society","year":"2009","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.kint.2024.03.011","article-title":"Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy","volume":"105","author":"Bellur","year":"2024","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.kint.2024.06.016","article-title":"The significance of subclassifying focal segmental glomerulosclerosis lesions (S1) in IgA nephropathy","volume":"106","author":"Chen","year":"2024","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026013001372738300_bib12","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/ndt\/gfy337","article-title":"Reproducibility of the Oxford Classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort","volume":"34","author":"Bellur","year":"2019","journal-title":"Nephrol Dialysis Transplant"},{"key":"2026013001372738300_bib13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/242717","article-title":"Use of CHAID decision trees to formulate pathways for the early detection of metabolic syndrome in young adults","volume":"2014","author":"Miller","year":"2014","journal-title":"Comput Math Meth Med"},{"key":"2026013001372738300_bib14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal Segmental Glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026013001372738300_bib15","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1097\/01.ASN.0000095639.56212.BF","article-title":"Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin\u2013angiotensin system","volume":"14","author":"Lai","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2026013001372738300_bib16","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1046\/j.1523-1755.2002.00269.x","article-title":"Podocytopenia and disease severity in IgA nephropathy","volume":"61","author":"Lemley","year":"2002","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/ndt\/gfn441","article-title":"Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy","volume":"24","author":"Lai","year":"2009","journal-title":"Nephrol Dialysis Transplant"},{"key":"2026013001372738300_bib18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00467-016-3358-9","article-title":"Mechanical challenges to the glomerular filtration barrier: adaptations and pathway to sclerosis","volume":"32","author":"Kriz","year":"2017","journal-title":"Pediatric Nephrol"},{"key":"2026013001372738300_bib19","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/sj.ki.5000160","article-title":"Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants","volume":"69","author":"Thomas","year":"2006","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib20","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1111\/j.1523-1755.2004.00563.x","article-title":"Glomerular tip lesion: a distinct entity within the minimal change disease\/focal segmental glomerulosclerosis spectrum","volume":"65","author":"Stokes","year":"2004","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ki.2010.466","article-title":"Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy I. Immunohistochemical studies","volume":"79","author":"Hill","year":"2011","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.kint.2022.02.037","article-title":"Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis","volume":"102","author":"Li","year":"2022","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/01913123.2023.2256836","article-title":"A closer look: ultrastructural evaluation of high-risk progression IgA nephropathy","volume":"47","author":"Terinte-Balcan","year":"2023","journal-title":"Ultrastruct Pathol"},{"key":"2026013001372738300_bib24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1523-1755.2005.00162.x","article-title":"Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesio1","volume":"67","author":"Howie","year":"2005","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib25","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1097\/01.ASN.0000135051.62500.97","article-title":"Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants","volume":"15","author":"Chun","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2026013001372738300_bib26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ki.2010.460","article-title":"Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies","volume":"79","author":"El Karoui","year":"2011","journal-title":"Kidney Int"},{"key":"2026013001372738300_bib27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/0886022X.2022.2083974","article-title":"Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy","volume":"44","author":"Shen","year":"2022","journal-title":"Renal Failure"},{"key":"2026013001372738300_bib28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.ajkd.2019.03.416","article-title":"Microangiopathic lesions in IgA nephropathy: a cohort study","volume":"74","author":"Cai","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2026013001372738300_bib29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/nep.14343","article-title":"Pathology of IgA nephropathy: a global perspective","volume":"29","author":"Roberts","year":"2024","journal-title":"Nephrology"},{"key":"2026013001372738300_bib30","doi-asserted-by":"publisher","first-page":"2486567","DOI":"10.1080\/0886022X.2025.2486567","article-title":"Global glomerulosclerosis proportions predict nephropathy progression in IgA nephropathy: a multicenter retrospective analysis with propensity score matching","volume":"47","author":"Zou","year":"2025","journal-title":"Renal Failure"},{"key":"2026013001372738300_bib31","doi-asserted-by":"crossref","first-page":"813603","DOI":"10.3389\/fmed.2022.813603","article-title":"Intensive systolic blood pressure lowering and kidney disease progression in IgA nephropathy: a cohort study","volume":"9","author":"Yu","year":"2022","journal-title":"Front Med"},{"key":"2026013001372738300_bib32","doi-asserted-by":"crossref","article-title":"Intensive blood pressure control and the progression of IgA nephropathy: a cohort study using marginal structural models","author":"Tang","DOI":"10.1093\/ndt\/gfad139"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf162\/64078691\/gfaf162.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/2\/297\/64078691\/gfaf162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/2\/297\/64078691\/gfaf162.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:37:34Z","timestamp":1769755054000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/2\/297\/8237448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,18]]},"published-print":{"date-parts":[[2026,1,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf162","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,8,18]]}}}